Logo - springer
Slogan - springer

Economics - Public Finance | Aims and Scope: BioDrugs

Aims and Scope: BioDrugs

BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease. The Journal includes:

  • Definitive reviews on topics relating to the development and use of biotechnology in healthcare and the management of disease.
  • Systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement.
  • Original research articles on the clinical development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products.
  • Leading/Current Opinion articles providing an overview of contentious or emerging issues and key regulatory and ethical issues.
  • Adis Drug Evaluations reviewing the properties and place in therapy of biotechnology-based drugs. 
  • Adis Biosimilar Briefs summarizing key characteristics and clinical use of biosimilar drugs.   

Articles published in BioDrugs may be accompanied by lay-level summaries to assist patients, caregivers  and others in understanding important medical advances.

 

All manuscripts are subject to peer review by international experts. Letters to the editor related to articles published in the Journal are welcomed and will be considered for publication.